Company Projected Revenue: MacroGenics Inc (MGNX)

Patents for DART platforms and stringent FDA oversight create barriers that, combined with pressure from pharma behemoths, drive volatility. The trend of MacroGenics, Inc. (MGNX) future sales visualizes this confrontation, where the current mark equals 0.11. The development of MacroGenics, Inc. (MGNX) relies on a specific rollout cycle for targeted drugs, making commercial success the primary driver regardless of the external economy.

Company Future Sales Volume: MacroGenics Inc. (MGNX) for 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for MacroGenics Inc. (MGNX)

- stock quotes and analyst forecast:

Stock Price MacroGenics Inc.|MGNX - Average Forecast Price

- company stock exchange capitalization indicators:

Market Value MacroGenics|MGNX - Value Adjusted for Debt and Cash

- balance sheet equity data:

Net Assets per Single Share MacroGenics|MGNX - Company Net Assets|Market Capitalization to Book Value Ratio macrogenics.com|MGNX - Company Total Assets

- debt burden and liquidity indicators:

- company profitability and valuation multiples indicators:

MGNX - Company Net Income|Expected Profit MacroGenics, Inc.|MGNX - Price to Earnings Multiple|Forward P/E Multiple MacroGenics Inc.|MGNX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple MacroGenics|MGNX - Operating profit before deduction of amortization|Earnings per share for the last twelve months MacroGenics|MGNX - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months macrogenics.com|MGNX - Earnings per share increase in current year|Earnings growth forecast for next year MacroGenics, Inc.

- total revenue and sales volume data:

MGNX - Company Gross Revenue|Company Projected Revenue MacroGenics Corp|MGNX - Market Cap to Revenue Ratio|Forward P/S Multiple MacroGenics|MGNX - Revenue Growth YoY (Last 12 Months)

Fundamental valuation:MGNX MacroGenics Inc.

Future sales volume represents the aggregate analyst consensus forecast for the business's expected cash inflows. For MacroGenics, Inc. (MGNX), this metric reflects the monetization potential of the DART platform and future licensing payments from partners. By analyzing the future sales volume chart, an investor assesses market expectations regarding the commercialization of oncology drugs. This metric measures fundamental revenue stability through the lens of future contracts. The indicator's trend confirms or refutes the validity of the current market value of the shares.

Competitors of MacroGenics, Inc. (MGNX)